Advertisement
Letter to the Editor| Volume 352, ISSUE 1-2, P122-124, May 15, 2015

Download started.

Ok

Fatal intracerebral haemorrhage following intravenous thrombolysis for acute ischaemic stroke: A hidden role for cerebral amyloid angiopathy?

Published:March 26, 2015DOI:https://doi.org/10.1016/j.jns.2015.03.030
      Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is currently the only approved therapy for acute ischemic stroke. However, intracerebral haemorrhage (ICH) remains the most feared and devastating complication of intravenous thrombolysis [
      • Derex L.
      • Nighoghossian N.
      Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update.
      ]. We report a case of a patient who suffered a catastrophic haemorrhage following intravenous thrombolysis for stroke, related to previously unsuspected severe cerebral amyloid angiopathy (CAA) found on autopsy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Derex L.
        • Nighoghossian N.
        Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update.
        J Neurol Neurosurg Psychiatry. 2008; 79: 1093-1099
        • Charidimou A.
        • Gang Q.
        • Werring D.J.
        Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum.
        J Neurol Neurosurg Psychiatry. 2012; 83: 124-137
        • Mazya M.
        • Egido J.A.
        • Ford G.A.
        • Lees K.R.
        • Mikulik R.
        • Toni D.
        • et al.
        Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (SITS) symptomatic intracerebral hemorrhage risk score.
        Stroke. 2012; 43: 1524-1531
        • McCarron M.O.
        • Nicoll J.A.
        Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.
        Lancet Neurol. 2004; 3: 484-492
        • Mattila O.S.
        • Sairanen T.
        • Laakso E.
        • Paetau A.
        • Tanskanen M.
        • Lindsberg P.J.
        Cerebral amyloid angiopathy related hemorrhage after stroke thrombolysis: case report and literature review.
        Neuropathology. 2015; 35: 70-74
        • Ly J.V.
        • Rowe C.C.
        • Villemagne V.L.
        • Zavala J.A.
        • Ma H.
        • O'Keefe G.
        • et al.
        Cerebral beta-amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage.
        Ann Neurol. 2010; 68: 959-962
        • Charidimou A.
        • Kakar P.
        • Fox Z.
        • Werring D.J.
        Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis.
        J Neurol Neurosurg Psychiatry. 2013; 84: 277-280
        • Shoamanesh A.
        • Kwok C.S.
        • Lim P.A.
        • Benavente O.R.
        Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis.
        Int J Stroke. 2013; 8: 348-356
        • Greenberg S.M.
        • Salman R.A.
        • Biessels G.J.
        • van Buchem M.
        • Cordonnier C.
        • Lee J.M.
        • et al.
        Outcome markers for clinical trials in cerebral amyloid angiopathy.
        Lancet Neurol. 2014; 13: 419-428